Search research articles
Contact Us
Filters
Showing results (1-10 of 282) with videos related to
Page
of 29
Sort By:
Methodsx
|
July 5, 2022
Nonparametric percentile curve estimation for a nonnegative marker with excessive zeros
Oke Gerke, Robyn L McClelland
JACC. Cardiovascular Imaging
|
June 19, 2017
Incorporating Coronary Artery Calcium Into Global Risk Scoring
Robyn L McClelland, Michael J Blaha
Statistics in Medicine
|
March 6, 2014
Extending the Bayesian Adjustment for Confounding algorithm to binary treatment covariates to estimate the effect of smoking on carotid intima-media thickness: the Multi-Ethnic Study of Atherosclerosis
Geneviève Lefebvre, Joseph A Delaney, Robyn L McClelland
The Journal of Rheumatology
|
January 8, 2008
Clustering of extraarticular manifestations in patients with rheumatoid arthritis
Carl Turesson, Robyn L McClelland, Teresa Christianson, et al.
Statistical Methods in Medical Research
|
July 10, 2018
A method to account for covariate-specific treatment effects when estimating biomarker associations in the presence of endogenous medication use
Andrew J Spieker, Joseph Ac Delaney, Robyn L McClelland
BMC Medical Research Methodology
|
June 27, 2013
Using imputed pre-treatment cholesterol in a propensity score model to reduce confounding by indication: results from the multi-ethnic study of atherosclerosis
Neal W Jorgensen, Christopher T Sibley, Robyn L McClelland
Archives of Neurology
|
July 23, 2003
Emergency intubation for respiratory failure in Guillain-Barré syndrome
Eelco F M Wijdicks, Robert D Henderson, Robyn L McClelland
Neurology
|
October 15, 2003
Stroke risk in anticoagulated patients with atrial fibrillation undergoing endoscopy
David J Blacker, Eelco F M Wijdicks, Robyn L McClelland
Mayo Clinic Proceedings
|
March 11, 2005
Postoperative stupor and coma
Elske C Gootjes, Eelco F M Wijdicks, Robyn L McClelland
Pharmacoepidemiology and Drug Safety
|
October 1, 2015
Evaluating the treatment effects model for estimation of cross-sectional associations between risk factors and cardiovascular biomarkers influenced by medication use
Andrew J Spieker, Joseph A C Delaney, Robyn L McClelland
Page
of 29
Search research articles
Search
Showing results (1-10 of 282) with videos related to
Sort By:
Page
of 29
Methodsx
|
July 5, 2022
Nonparametric percentile curve estimation for a nonnegative marker with excessive zeros
Oke Gerke, Robyn L McClelland
JACC. Cardiovascular Imaging
|
June 19, 2017
Incorporating Coronary Artery Calcium Into Global Risk Scoring
Robyn L McClelland, Michael J Blaha
Statistics in Medicine
|
March 6, 2014
Extending the Bayesian Adjustment for Confounding algorithm to binary treatment covariates to estimate the effect of smoking on carotid intima-media thickness: the Multi-Ethnic Study of Atherosclerosis
Geneviève Lefebvre, Joseph A Delaney, Robyn L McClelland
The Journal of Rheumatology
|
January 8, 2008
Clustering of extraarticular manifestations in patients with rheumatoid arthritis
Carl Turesson, Robyn L McClelland, Teresa Christianson, et al.
Statistical Methods in Medical Research
|
July 10, 2018
A method to account for covariate-specific treatment effects when estimating biomarker associations in the presence of endogenous medication use
Andrew J Spieker, Joseph Ac Delaney, Robyn L McClelland
BMC Medical Research Methodology
|
June 27, 2013
Using imputed pre-treatment cholesterol in a propensity score model to reduce confounding by indication: results from the multi-ethnic study of atherosclerosis
Neal W Jorgensen, Christopher T Sibley, Robyn L McClelland
Archives of Neurology
|
July 23, 2003
Emergency intubation for respiratory failure in Guillain-Barré syndrome
Eelco F M Wijdicks, Robert D Henderson, Robyn L McClelland
Neurology
|
October 15, 2003
Stroke risk in anticoagulated patients with atrial fibrillation undergoing endoscopy
David J Blacker, Eelco F M Wijdicks, Robyn L McClelland
Mayo Clinic Proceedings
|
March 11, 2005
Postoperative stupor and coma
Elske C Gootjes, Eelco F M Wijdicks, Robyn L McClelland
Pharmacoepidemiology and Drug Safety
|
October 1, 2015
Evaluating the treatment effects model for estimation of cross-sectional associations between risk factors and cardiovascular biomarkers influenced by medication use
Andrew J Spieker, Joseph A C Delaney, Robyn L McClelland
Page
of 29